Company / Interest Expense per Share
Xeris Biopharma Holdings, Inc. Interest Expense per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.20
FY2023
5-year range
$0.06 / $0.20
FY2020-FY2023
Trend
+239.6%
vs FY2022
Sector context
#20 of 43
Health Care
What the data says
Interest Expense per Share changed +240% YoY in FY2023, a notable deviation from the 3-year average annual change of +47%.
Based on SEC 10-K filings.
0.20 in FY2023 with a 3-year CAGR of -7.9%.
Increased from $0.17 to $0.20 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -7.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#24 of 43 in Health CareTop 53% of 43This company $0.20 Sector average $18.61
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 239.6% year-over-year.
- Ranks #20 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.20 | +239.6% |
| FY2022 | $0.06 | -65.9% |
| FY2021 | $0.17 | -32.6% |
| FY2020 | $0.25 | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026